Wall Street is drifting Thursday as gains for fashion brands and cigarette makers help offset drops for Ford Motor and ...

In Colombo’s view, the stock market looks vulnerable due to the widespread and excessive optimism. As a result, the market is ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...

A stock market forecast is tricky, to say the least. But market-topping signals are not so daunting. Obviously, it's ...

Asian shares were trading mostly higher Thursday, after a Wall Street rally that followed profit reports from major companies ...

Take them with a grain of salt, but forecasts can help inform your financial plan. The best use case for investors for ...

Starbucks’ first-quarter earnings marked a promising start under the leadership of CEO Brian Niccol, despite ongoing challenges in key metrics such as comparable ...

Hans Mosesmann at Rosenblatt Securities recently reiterated his AMD target price of $250 per share. That forecast implies 127 ...

Palantir’s Q4 revealed a 45% operating margin and 36% revenue growth, but its shares reflect over five years’ growth already.

All three major stock indexes closed higher on Wednesday, rebounding from declines earlier in the session as investors ...

Wall Street drifted higher as gains for most stocks outweighed drops for Alphabet and some other big-name companies following ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.